4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001415889-24-019504
EVP, R&D AND CSO sold 105,931 shares at an average $6.95 ($736,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morisset Valerie EVP, R&D AND CSO | 2024-07-09 | Sale | −5,931 | $6.66 | $39,500 | 444,683 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-10 | Sale | −50,000 | $6.83 | $341,500 | 394,683 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-11 | Sale | −50,000 | $7.11 | $355,500 | 344,683 | D |
| Open-market sales · 105,931 sh · avg $6.95 · $736,500 | |||||||
Loading xslF345X05/form4-07122024_120744.xml…